JPRN-UMIN000004610招募中未知
Clinical prospective study to investigate efficacy and safety of immune-cell therapy for malignant tumors - Prospective Study of immune-cell therapy for malignant tumors
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: 1) T cell, NK cell lymphoma and leukemia 2) HTLV-I Ab and/or HIV Ab positive (LAK therapy), HIV Ab positive (DC therapy) 3) interstitial pneumonia, including their history or predisposition of them, 4) Active autoimmune diseases 5) Active cardiac disease 6) Serious drug allergy 7) Pregnancy woman, or woman with suspected pregnancy, lactating woman 8) Responsible doctors judged the patient inappropriate for the clinical study
研究者
相似试验
已完成
不适用
Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors.JPRN-UMIN000008046Seta Clinic Group20
已完成
不适用
Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapyMalignant tumor (all HLA types)JPRN-UMIN000009447Seta Clinic Group5
已完成
不适用
The prospective study of the clinical efficacy/adverse event of regorafenib in unresectable metastatic and advanced colorectal cancerColorectal cancerJPRN-UMIN000015404Department of Clinical Oncology, Akita University Hospital50
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisactinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC) - Verrumal in AKactinic keratosisEUCTR2006-005432-24-DEHermal Kurt Herrmann GmbH & Co OHG15